| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/06/2004 | US6716966 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 04/06/2004 | US6716880 Function as sulfatase and/or blocking estrogen receptors; prophylaxis and therapy |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716821 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 04/06/2004 | US6716817 Method of treatment of female infertility |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716458 Nutritional supplement comprising manganese complexed or chelated by matrix formed from composition including at least brown sugar, where element is not covalently bound to matrix |
| 04/06/2004 | US6716456 Combining particles of insoluble substrate with membrane forming ionic polymer and aqueous buffer solution with high ionic strength, forming coacervate by adding water binding agent to form aqueous complex and cause phase separation |
| 04/06/2004 | US6716452 Active agent delivery systems and methods for protecting and administering active agents |
| 04/06/2004 | US6716451 Formulation for vitamin e doses with increased antioxidant capacity comprising d-alpha-tocopherol, dl-alpha-tocopherol, mixed tocopherols, and tocotrienols in forms comprising inseparable tocopherols |
| 04/06/2004 | US6716447 Stable carotene xanthophyll beadlet compositions and methods of use |
| 04/06/2004 | US6716445 Time-release agents, therapy, drug delivery |
| 04/06/2004 | US6716428 Synthetic peptides mimick epitope regions of hormones such as human chorionic gonadotropin can be conjugated to carrier; contraceptives, anticarcinogenic agents |
| 04/06/2004 | US6716426 Administering xanthine oxidase conjugated to polyoxyethylene glycol and hypoxanthine or xanthine |
| 04/06/2004 | US6716420 Methods of use and of making a mascara comprising at least one coloring agent and at least one heteropolymer |
| 04/06/2004 | US6716418 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | US6716414 Aerosol solution for use in an aerosol inhaler |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 04/06/2004 | CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
| 04/01/2004 | WO2004027897A1 Method for manufacture of films containing insoluble solids embedded in cellulose-based films |
| 04/01/2004 | WO2004027385A2 Engineering of material surfaces |
| 04/01/2004 | WO2004027045A2 Polymer-linker-drug conjugates for targeted drug delivery |
| 04/01/2004 | WO2004026941A1 Drug delivery |
| 04/01/2004 | WO2004026912A1 Solubilising polysaccharides substituted with hydrophilic and hydrophobic groups |
| 04/01/2004 | WO2004026911A1 Obtaining and use of therapeutic antibodies entering into the cell |
| 04/01/2004 | WO2004026362A2 Dri nasal sprays |
| 04/01/2004 | WO2004026345A1 Control of nitric oxide bioactivity by perfluorocarbons |
| 04/01/2004 | WO2004026343A1 Site-specific gene conversion promoter and gene therapeutic |
| 04/01/2004 | WO2004026335A1 Pharmaceutical composition comprising carriers for products |
| 04/01/2004 | WO2004026327A1 Homing peptides to receptors of heart vasculature |
| 04/01/2004 | WO2004026313A1 Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
| 04/01/2004 | WO2004026297A1 Preparation for external use |
| 04/01/2004 | WO2004026278A1 Copolymer and hemoprotein based novel compounds and uses thereof |
| 04/01/2004 | WO2004026262A2 Abuse-resistant pharmaceutical compositions |
| 04/01/2004 | WO2004026259A2 Transdermal compositions |
| 04/01/2004 | WO2004026231A2 Formulation for lipophilic agents |
| 04/01/2004 | WO2004026120A2 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 04/01/2004 | WO2004026111A2 Flexible and/or elastic brachytherapy seed or strand |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004017998A3 Topical emulsion- gel composition comprising diclofenac sodium |
| 04/01/2004 | WO2004013206A3 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof |
| 04/01/2004 | WO2004011054A3 Injectable multimodal polymer depot compositions and uses thereof |
| 04/01/2004 | WO2004009123A3 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/01/2004 | WO2004004639A3 A novel stable formulation |
| 04/01/2004 | WO2003106659A3 Aptamer-toxin molecules and methods for using same |
| 04/01/2004 | WO2003106536A3 Heat-sensitive polymers and heat reversible gels derived therefrom |
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003105767A3 Antifungal parenteral products |
| 04/01/2004 | WO2003104402A3 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 04/01/2004 | WO2003103644A3 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 04/01/2004 | WO2003099830A3 Cardiolipin compositions, methods of preparation and use |
| 04/01/2004 | WO2003099256A3 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES) |
| 04/01/2004 | WO2003094905A8 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 04/01/2004 | WO2003091398A3 Compositions and methods for stem cell delivery |
| 04/01/2004 | WO2003088913A3 Peptide deformylase activated prodrugs |
| 04/01/2004 | WO2003087220A3 Solid emulsions based on thermoplastic elastomers |
| 04/01/2004 | WO2003086491B1 Tissue defect dressings comprising a keratin network |
| 04/01/2004 | WO2003084518A3 Oral suspension of active principle microcapsules |
| 04/01/2004 | WO2003084517A3 Oral suspension of amoxicillin capsules |
| 04/01/2004 | WO2003084481A3 Biological affinity based delivery systems |
| 04/01/2004 | WO2003082926A3 Antimicrobial polymer conjugates |
| 04/01/2004 | WO2003077865A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003077864A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003075834A3 Activated protein c formulations |
| 04/01/2004 | WO2003070888A3 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003070227A9 Taste-masked film-type or wafer-type medicinal preparation |
| 04/01/2004 | WO2003066021A3 Drug nanoparticles with lysozyme surface stabiliser |
| 04/01/2004 | WO2003064619A3 Long-acting hormone and growth factor compositions and uses thereof |
| 04/01/2004 | WO2003062819A3 Water- soluble derivatives of lipophilic drugs |
| 04/01/2004 | WO2003054146A3 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 04/01/2004 | WO2003050283A3 A structure for presenting desired peptide sequences |
| 04/01/2004 | WO2003041642A3 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 04/01/2004 | WO2003009842A8 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063916 Bactericides; antibiotics |
| 04/01/2004 | US20040063912 Comprises interferon-immunoglobulin fusion protein for use in aerosol delivery of therapeutics for treatment or prevention of disease |
| 04/01/2004 | US20040063905 Armed peptides |
| 04/01/2004 | US20040063886 Water-soluble or water-swellable crosslinked copolymers |
| 04/01/2004 | US20040063881 Zwitterionic polymers |
| 04/01/2004 | US20040063794 Vehicle for topical delivery of anti-inflammatory compounds |
| 04/01/2004 | US20040063791 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063722 Antifungal ketoconazole composition for topical use |
| 04/01/2004 | US20040063718 Targeted therapeutics and uses thereof |
| 04/01/2004 | US20040063689 Compositions containing alpha-2-adrenergic agonist components |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063663 Acylated cyclodextrin: guest molecule inclusion complexes |
| 04/01/2004 | US20040063661 Treatment of statin side effects |
| 04/01/2004 | US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 04/01/2004 | US20040063639 Storage stable buffered liquid and lyophilized materials |
| 04/01/2004 | US20040063637 Aqueous formulation of fusion inhibitor and polyol; minimizes number of injections and site reaction |